Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Magnificent Ventures is a venture capital organization founded to bridge innovation and impact. Established with a mission to invest in transformative technologies, the firm enhances human health, longevity, and potential. The organization is notable for its commitment to donating 80% of its profits generated through carried interest to initiatives such as the Root Cause Project and WHEN Justice, which focus on addressing environmental justice and societal issues.
Currently, Magnificent Ventures operates with a focus on sectors that include food, climate, and healthcare. The firm is in its early stages, with a Framer-hosted landing page indicating a pre-launch status. Although specific fund sizes and team members are not disclosed, the firm aims to generate and redirect resources toward addressing pressing global challenges. Its investment strategy spans from seed to pre-IPO stages, reflecting a broad approach to funding innovative ideas.
Magnificent Ventures invests in visionary ideas across a spectrum from seed to pre-IPO stages. The firm targets sectors related to food, environment, and human wellbeing, aligning its investment strategy with its mission to generate and redirect resources toward addressing pressing global challenges. The organization seeks transformative technologies that enhance human health and longevity, indicating a strong preference for impactful innovations.
Investment checks are not specifically disclosed, but the firm emphasizes a commitment to addressing societal issues through its profit donation model. This unique approach positions Magnificent Ventures as an impact-first venture capital firm, aiming to create significant social and environmental benefits alongside financial returns.
Magnificent Ventures has a notable portfolio company, CoRegen, which is developing a cancer treatment using CRISPR gene editing technology. CoRegen's innovative approach aims to empower the immune system to target and eradicate cancer cells without the toxicity associated with traditional therapies. Their pre-clinical studies have shown promising results in eliminating cancer in mice, highlighting the potential impact of their work in the healthcare sector.
As of now, CoRegen represents the sole company in Magnificent Ventures' portfolio, reflecting the firm's focused investment strategy in transformative healthcare solutions.
Roland Peralta, Founder - Roland has a background in venture capital and impact investing, focusing on bridging innovation with social impact.
Anand Ravipati, Managing Director - Anand brings experience in managing investments and strategic initiatives within the firm.
Jackie Biner, General Counsel - Jackie oversees legal matters and compliance, ensuring the firm operates within regulatory frameworks.
Rafael Quintero, CFO - Rafael manages the financial operations of the firm, contributing to its strategic financial planning.
To pitch Magnificent Ventures, founders should utilize the contact options available on the firm's website. A well-structured pitch deck that outlines the startup's mission, market potential, and alignment with the firm's focus areas is essential. Specific response time expectations are not detailed, but founders should anticipate a thorough review process given the firm's impact-oriented approach.
As of now, there are no recent announcements or notable events reported for Magnificent Ventures. The firm appears to be in its early stages, with a focus on establishing its presence in the venture capital space.
What are Magnificent Ventures' investment criteria?
Magnificent Ventures invests in transformative technologies across food, climate, and healthcare sectors, focusing on seed to pre-IPO stages. The firm seeks visionary ideas that can address pressing global challenges.
How can I apply or pitch to Magnificent Ventures?
Founders interested in pitching to Magnificent Ventures should reach out through their website. Specific application forms or portals are not detailed, but a clear presentation of the business idea and its impact is essential.
What makes Magnificent Ventures different from other VCs?
The firm is committed to donating 80% of its profits generated through carried interest to social initiatives, which is a significant differentiator in the venture capital space. This impact-first approach aims to address environmental justice and societal issues.
What is the geographic scope of Magnificent Ventures?
The firm does not specify geographic limitations in its investment strategy, indicating a potential openness to global opportunities in its targeted sectors.
What is the fund size and check size for investments?
Specific fund size and check size information are not disclosed. However, the firm operates within a broad investment range from seed to pre-IPO stages, suggesting flexibility in funding amounts based on the opportunity.
What kind of post-investment involvement can founders expect?
Details regarding post-investment involvement are not explicitly stated. However, given the firm's focus on impactful technologies, it is likely that they provide support aligned with their mission to enhance human health and wellbeing.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.